Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
390.48
-57.02 (-12.74%)
Dec 19, 2024, 10:36 AM EST - Market open
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
30
Consensus Rating
Buy
Price Target
$519.88
Upside
+33.14%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Hold Maintains $490 → $494 | Hold | Maintains | $490 → $494 | +26.51% | Dec 16, 2024 |
Jefferies | Jefferies | Hold → Strong Buy Upgrades $500 → $550 | Hold → Strong Buy | Upgrades | $500 → $550 | +40.85% | Dec 9, 2024 |
Citigroup | Citigroup | Strong Buy Initiates $575 | Strong Buy | Initiates | $575 | +47.25% | Nov 14, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Sell Maintains $361 → $408 | Strong Sell | Maintains | $361 → $408 | +4.49% | Nov 6, 2024 |
Scotiabank | Scotiabank | Hold Maintains $480 → $486 | Hold | Maintains | $480 → $486 | +24.46% | Nov 5, 2024 |
UBS | UBS | Strong Buy Maintains $562 → $586 | Strong Buy | Maintains | $562 → $586 | +50.07% | Nov 5, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $480 | Buy | Reiterates | $480 | +22.93% | Nov 5, 2024 |
RBC Capital | RBC Capital | Hold Maintains $437 → $451 | Hold | Maintains | $437 → $451 | +15.50% | Nov 5, 2024 |
JP Morgan | JP Morgan | Buy Maintains $510 → $503 | Buy | Maintains | $510 → $503 | +28.82% | Nov 5, 2024 |
Morgan Stanley | Morgan Stanley | Hold Maintains $473 → $476 | Hold | Maintains | $473 → $476 | +21.90% | Nov 5, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $550 → $540 | Buy | Maintains | $550 → $540 | +38.29% | Oct 30, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $600 | Strong Buy | Reiterates | $600 | +53.66% | Oct 21, 2024 |
UBS | UBS | Strong Buy Maintains $477 → $562 | Strong Buy | Maintains | $477 → $562 | +43.92% | Oct 17, 2024 |
Scotiabank | Scotiabank | Hold Initiates $480 | Hold | Initiates | $480 | +22.93% | Oct 16, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $550 → $541 | Strong Buy | Maintains | $550 → $541 | +38.55% | Oct 14, 2024 |
Raymond James | Raymond James | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 10, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.